Philip Morris International (PMI) is selling inhaled drug specialist Vectura to Molex Asia Holdings for a fraction of the £1.1 billion ($1.45 billion) it paid for the business three years ago. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback